Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:22 PM
Ignite Modification Date:
2025-12-25 @ 1:41 PM
NCT ID:
NCT01096992
Group ID:
EG002
Title:
Phase 1 40 mg/m^2
Description:
Bendamustine, Fludarabine + Rituximab
Bendamustine: Phase 1: 40 mg/m\^2 IV on Days 1,2,3 (after fludarabine)
Fludarabine: Course 1: 20 mg/m\^2 intravenous (IV) on Days 2,3,4 Courses 2-6: 20 mg/m\^2 IV, Days 1,2,3
Rituximab: Course 1: 375 mg/m\^2 IV, Day 4 (after fludarabine) Courses 2-6: 500 mg/m\^2 IV, Day 1
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
6
Other Number Affected:
6
Other Number At Risk:
6
Study:
NCT01096992
Results Section:
NCT01096992
Adverse Events Module:
NCT01096992